Search - tctmd.com

Displaying 61 - 80 of 132

Sort: Relevancy | Date

News Daily News

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Michael O'Riordan

March 08, 2019

News Daily News

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Yael L. Maxwell

February 28, 2019

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

Caitlin E. Cox

October 31, 2018

Presentation TCT 2018

Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction: First Results of the CAMI1 Study

Presenter: Ulrich P. Jorde, John M. Lasala, Christoph Garlichs

September 21, 2018

News Daily News

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Yael L. Maxwell

August 03, 2018

News Daily News

Atrial Fibrillation Risk Increased in People With Asthma

Michael O'Riordan

July 13, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

Todd Neale

June 04, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Caitlin E. Cox

May 16, 2018

News Daily News

It Takes a Village: Diverse Gut Microbes Linked to Arterial Health in Women

Caitlin E. Cox

May 15, 2018

News Conference News SCAI 2018

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

L.A. McKeown

May 01, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Daily News

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

Shelley Wood

January 17, 2018

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

Advertisement

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction: First Results of the CAMI1 Study

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Atrial Fibrillation Risk Increased in People With Asthma

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

It Takes a Village: Diverse Gut Microbes Linked to Arterial Health in Women

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content